CEP290 Antikörper (C-Term)
Kurzübersicht für CEP290 Antikörper (C-Term) (ABIN1100758)
Target
Alle CEP290 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Reacts with mouse 290 kD Cep290 protein. May cross reacts with proteins from rat and human due to sequences homology.
-
Aufreinigung
- Protein A purified
-
Immunogen
-
Synthetic peptide derived from C-ter domain of mouse Cep290.
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Mouse
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- 100 mM Tris-glycine, 2 % sucrose
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at 4°C. For extended periods store in aliquots at -20°C.
-
-
- CEP290 (Centrosomal Protein 290kDa (CEP290))
-
Andere Bezeichnung
- CEP290
-
Hintergrund
-
Name/Gene ID: CEP290
Synonyms: CEP290, 3H11Ag, Cancer/testis antigen 87, Centrosomal protein of 290 kDa, CTCL tumor antigen se2-2, CT87, Centrosomal protein 290 kDa, JBTS5, JBTS6, Meckel syndrome, type 4, Nephrocytsin-6, NPHP6, POC3, KIAA0373, Rd16, MKS4, SLSN6, BBS14, Nephrocystin-6, Prostate cancer antigen T21, Tumor antigen se2-2 -
Gen-ID
- 80184
-
UniProt
- O15078
-
Pathways
- cAMP Metabolic Process, M Phase
Target
-